| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 60.9K | 7.1% | 11.1% |
| Total Income | 60.9K | 7.1% | 11.1% |
| Expenditure | 60.4K | 6.9% | 11.6% |
| PBT | 392.00 | 37.8% | 41.0% |
| Net Profit | 399.00 | 14.6% | 21.1% |
| OPM | 0.83% | 0.24pp | 0.50pp |
| NPM | 0.66% | 0.06pp | 0.27pp |
| EPS | — |
Cardinal Health Reports Q3 FY26 Revenue Up 11% to $60.9 Billion
03 May 2026 · 3 May, 6:04 pm
Summary
Cardinal Health reported an 11% increase in revenue to $60.9 billion for the third quarter of fiscal year 2026. GAAP operating earnings decreased by 30% to $509 million, while non-GAAP operating earnings increased by 18% to $956 million. The company raised its fiscal year 2026 non-GAAP EPS guidance to $10.70 to $10.80. CEO Jason Hollar noted the strong operating performance led by Pharmaceutical and Specialty Solutions and the company's three growth businesses.
Key Highlights
- 1
Cardinal Health's revenue increased by 11% to $60.9 billion in the third quarter of fiscal year 2026.
- 2
GAAP operating earnings decreased by 30% to $509 million, while GAAP diluted EPS decreased by 20% to $1.69.
- 3
Non-GAAP operating earnings increased by 18% to $956 million, and non-GAAP diluted EPS increased by 35% to $3.17.
- 4
The company raised and narrowed its fiscal year 2026 non-GAAP EPS guidance to $10.70 to $10.80.
- 5
Cardinal Health completed an additional $250 million share repurchase, bringing the FY26 repurchase total to $1.0 billion.
- 6
Pharmaceutical and Specialty Solutions segment revenue increased 11% to $56.1 billion.
- 7
Other segment revenue increased 31% to $1.7 billion, driven by growth across at-Home Solutions, Nuclear and Precision Health Solutions and OptiFreight Logistics.
Management Comments
Jason Hollar
“An excellent third quarter extends our FY26 momentum, due to the durability and resilience of our business,” “We were pleased to see strong operating performance led by Pharmaceutical and Specialty Solutions and our three growth businesses, positioning us for long-term value creation and giving us the confidence to again raise our fiscal 2026 outlook.”
Informational and educational content only. Not investment advice.